• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

Recent Advances in the Study of 1-(3-Methoxyphenyl)butan-2-one (CAS: 23037-58-3) in Chemical Biology and Pharmaceutical Research

1-(3-Methoxyphenyl)butan-2-one (CAS: 23037-58-3) is a chemical compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its methoxyphenyl and butanone functional groups, has been the subject of various studies aimed at exploring its biological activities, synthetic pathways, and therapeutic potential. The latest research highlights its role as a key intermediate in the synthesis of more complex molecules and its emerging pharmacological properties.

Recent studies have focused on the synthetic methodologies for producing 1-(3-Methoxyphenyl)butan-2-one with high yield and purity. A 2023 publication in the Journal of Organic Chemistry detailed an optimized catalytic process using palladium-based catalysts, which significantly improved the efficiency of the synthesis. This advancement is critical for scaling up production and ensuring the compound's availability for further pharmacological testing. Additionally, the study emphasized the importance of controlling reaction conditions to minimize byproducts, which could interfere with downstream applications.

In the realm of pharmacology, 1-(3-Methoxyphenyl)butan-2-one has shown promising results in preliminary in vitro and in vivo studies. Research published in Bioorganic & Medicinal Chemistry Letters reported that this compound exhibits moderate inhibitory activity against certain inflammatory enzymes, suggesting potential anti-inflammatory applications. Furthermore, molecular docking studies have revealed its ability to interact with specific protein targets involved in neurodegenerative diseases, opening new avenues for drug development in this area.

The compound's mechanism of action is also under investigation. A recent study in Chemical Biology & Drug Design utilized computational modeling and spectroscopic techniques to elucidate the binding interactions of 1-(3-Methoxyphenyl)butan-2-one with biological targets. The findings indicated that the methoxy group plays a crucial role in stabilizing these interactions, which could inform the design of derivatives with enhanced efficacy and selectivity. Such insights are invaluable for the rational development of new therapeutic agents.

Despite these advancements, challenges remain in the clinical translation of 1-(3-Methoxyphenyl)butan-2-one. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed through further preclinical studies. Collaborative efforts between chemists, biologists, and pharmacologists will be essential to overcome these hurdles and fully realize the compound's therapeutic potential. Future research directions may include the synthesis of analogs to improve pharmacological properties and the exploration of combination therapies to enhance efficacy.

In conclusion, 1-(3-Methoxyphenyl)butan-2-one (CAS: 23037-58-3) represents a versatile and promising compound in chemical biology and pharmaceutical research. Recent studies have advanced our understanding of its synthesis, biological activities, and mechanisms of action, paving the way for its potential application in drug development. Continued research and interdisciplinary collaboration will be key to unlocking its full potential and addressing the remaining challenges in its path to clinical use.

• 163683-23-6(2-Heptadecanone, 1-(3,5-dimethoxyphenyl)-)
• 29114-51-0(4-(3-methoxyphenyl)butan-2-one)
• 56438-64-3(2-Propanone, 1,3-bis(3-methoxyphenyl)-)
• 88488-70-4(2,4-Pentanedione, 1-(3-methoxyphenyl)-)
• 62291-16-1(2-Propanone, 1-(3-methoxyphenyl)-3-phenyl-)
• 267004-82-0(2-Pentadecanone, 1-(3,5-dimethoxyphenyl)-)
• 53917-01-4(1-(4-Methoxyphenyl)-2-butanone)
• 80055-27-2(2-Propanone, 1-(4-methoxyphenyl)-3-(4-methylphenyl)-)
• 3027-13-2(3-Methoxyphenylacetone)
• 18917-77-6(1-(3,5-Dimethoxyphenyl)propan-2-one)